Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 study
- Alwin Krämer
- , Tilmann Bochtler
- , Chantal Pauli
- , Kai-Keen Shiu
- , Natalie Cook
- , Juliana Janoski de Menezes
- , Roberto A Pazo-Cid
- , Ferran Losa
- , Debbie Gj Robbrecht
- , Jiří Tomášek
- , Cagatay Arslan
- , Mustafa Özgüroğlu
- , Michael Stahl
- , Frédéric Bigot
- , Sun Young Kim
- , Yoichi Naito
- , Antoine Italiano
- , Nasséra Chalabi
- , Gonzalo Durán-Pacheco
- , Chantal Michaud
- Universitatsbibliothek Heidelberg
- University of Zurich
- Ramsay Memorial Fellowship Trust
- Lincoln Clinical Haematology & Oncology
- Miguel Servet University Hospital
- ICO-Hospitalet
- Erasmus MC
- Masaryk Memorial Cancer Institute
- Izmir University of Economics
- Istanbul University Cerrahpasa
- Evang Kliniken Essen-Mitte
- Fondazione IRCCS
- University of Ulsan
- National Cancer Center East Hospital
- Institut Bergonié
- F Hoffman - La Roche Ltd
- SUNY Upstate Medical University
Research output: Contribution to journal › Article › peer-review